Clinical trial
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
NCT00331773 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00331773 |
|---|---|
| Title | Radiation Therapy in Treating Patients With Stage II Prostate Cancer |
| Official title | A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH NRG Oncology |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Radiation |
| Interventions | Conventional 3D-CRT or IMRT, Hypofractionated 3D-CRT or IMRT |
| Enrollment | 1,116 |
| Start date | Apr 1, 2006 |
| Primary completion | Jul 1, 2015 |
| Completion | Dec 22, 2022 |
| First posted | May 31, 2006 |
| Last update posted | Jan 18, 2023 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: